Held 6 & 7 February, 2024  |  Free Online Conference
Welcome to the Antimicrobial Chemotherapy Conference 2024. Explore the scientific programme and recordings below.
This virtual conference was jointly organised by GARDP and BSAC. For ACC2024, the collaborating organisations were the European Clinical Research Alliance on Infectious Diseases (Ecraid) and the Netherlands Antibiotic Development Platform (NADP). This conference is Royal College of Pathologists CPD accredited (8 credits).

Programme

Recorded content from this conference can be viewed below.

SESSION ONE: KEYNOTE PRESENTATION

View session one. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Dr Christopher Longshaw, Shionogi BV & BSAC Honorary Treasurer - View Bio

The Quirks of EUCAST: what to consider when hoping for breakpoints for a new agent - from EUCAST and others

Professor Gunnar Kahlmeter, Professor of Clinical bacteriology & Head of the EUCAST Development Laboratory - View Bio

Q&A

SESSION TWO: Drug discovery: new targets and new chemistry

View session two. This video consists of the following presentations:

Watch Presentation

Discovery of semi-synthetic antibiotics and adjuvants

Professor Jayanta Haldar, Jawaharlal Nehru Centre for Advanced Research (JNCASR), Bangalore, India - View Bio

Genome mining pipelines and tools to guide the discovery of new antibiotics

Professor Nadine Ziemert, German Centre for Infection Research (DZIF) - View Bio

AI to discover new antibiotics for Gram-negative bacteria

Dr Jon Stokes, McMaster University - View Bio

Q&A

SESSION THREE: Preclinical antimicrobial development

View session three. This video consists of the following presentations:

Watch Presentation

Bugworks: New gyrase inhibitors

Dr Shahul Hameed, Bugworks Research Inc. - View Bio

GangaGen: Klebicins

Mr Vivek Daniel Paul, GangaGen - View Bio

Q&A

SESSION FOUR: PANEL DISCUSSION: How useful/successful are the WHO Priority Pathogen lists at identifying future targets for Antimicrobial Discovery Programmes?

View session four. This video consists of the following presentations:

Watch Presentation

Panelists

Professor Stephan Harbarth, Geneva University Hospitals - View Bio

Dr Erin M Duffy, CARB-X - View Bio

Dr Hatim Sati, WHO AMR Division - View Bio

Closing remarks

Dr Alison Luckey, GARDP - View Bio

SESSION FIVE: Clinical development and use of new agents

View session five. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Dr Alison Luckey, GARDP - View Bio

Navigating the regulatory process for "niche" antibiotics - Lessons learned from a Pathogen-focused clinical development pathway

Dr John O’Donnell, Innoviva Specialty Therapeutics - View Bio

Role of data platform in antibiotic clinical development

Professor Philippe Guérin, University of Oxford - View Bio

Can we include assessment of risk of resistance in clinical trials for novel antibiotics? 

Dr Marco Cavaleri, European Medicines Agency (EMA) - View Bio

Q&A

SESSION SIX: ORAL POSTER PRESENTATIONS

View session six. This video consists of the following presentations:

Watch Presentation

Development of Novel Antibiotics Targeting Bacterial Transcription: Promising Antimicrobial Activity and Pharmacological Properties

Mr Cheuk Hei Kan, The Chinese University of Hong Kong, China

Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus in vitro and in vivo

Mr Abdul Akhir, CSIR-Central Drug Research Institute, India

Unveiling Overlooked Critical Parameters in the Hollow Fiber System for Tuberculosis Studies: Impact on Moxifloxacin Pharmacokinetics/Pharmacodynamics.

Dr Diana A. Aguilar Ayala, University of Zaragoza, Spain

Antimicrobial Chemotherapy in Neurological Disorders: A Call for Action in Low- and Middle-Income Countries (LMICs)

Dr M Faizan Siddqui, Osh State University, Kyrgyzstan & AIG Hospital, Asian Institute of Gastroenterology, India

Modified Carbapenem Inactivation Method (mCIM) as a tool of antibiotic stewardship for Gram negative bacteremia in Teaching Hospital Kandy

Dr Kaushila Dinithi Galgamuwa, National Hospital Kandy, Sri Lanka

Q&A

SESSION SEVEN: Ensuring long-term security of access to new antimicrobials

View session seven. This video consists of the following presentations:

Watch Presentation

Implementation of AMS strategy across a diverse nation(s)

Dr Abdul Ghafur, Apollo Hospitals, Chennai, India - View Bio

Monitoring resistance and consumption of new antibiotics: who, how, when 

Dr Dominique L Monnet, ARHAI & ECDC - View Bio

Antimicrobial shortages/supply chain analysis

Dr Esmita Charani, University of Cape Town - View Bio

Q&A

SESSION EIGHT: PANEL DISCUSSION: Are existing push and pull incentives sufficient to strengthen the antibiotic R&D pipeline and ensure treatments reach patients?

View session eight. This video consists of the following presentations:

Watch Presentation

Panelists:

Dr Lesley Ann Ogilvie, Global AMR R&D Hub - View Bio

Mr Luka Srot, IFPMA - View Bio

Dr Rohit Malpani, Advisor (consultant), GARDP - View Bio

Closing remarks

Dr Christopher Longshaw, Shionogi BV & BSAC Honorary Treasurer - View Bio

Virtual poster gallery

Click here to view the virtual poster gallery from the conference